Sign in

CIK 0001676725

  • Large accelerated filer

IDEAYA Biosciences, Inc.

Sign in to watch
Ticker
IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474268251
Phone
+1 650-443-6209
Business address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale SVP, Chief Scientific Officer sold 1,500 shares at $20.22 ($30,333)
  2. 4 Open-market sale SVP, Chief Scientific Officer sold 5,000 shares at $20.22 ($101,093)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale SVP, Chief Scientific Officer sold 5,000 shares at $20.74 ($103,697)
  12. 4 Open-market sale SVP, Head of Biology sold 2,000 shares at an average $21.03 ($42,052)
  13. 4 Open-market sale See Explanation of Responses sold 46,409 shares at $18.00 ($835,362)
  14. 4 Open-market sale SVP, Head of Biology sold 2,501 shares at an average $18.46 ($46,158)
  15. 4 Option exercise President and CEO acquired 8,000 shares (option exercise)
  16. 4 Option exercise SVP, Chief Scientific Officer acquired 7,750 shares (option exercise)
  17. 4 Other acquisition SVP, Chief Financial Officer acquired 444 shares (other)
  18. 4 Open-market sale SVP, General Counsel sold 1,979 shares at an average $15.37 ($30,410)
  19. 4 Open-market sale 10% owner sold 800,000 shares at $13.66 ($10,928,000)
  20. 4 Open-market buy 10% owner bought 2,531 shares at $13.32 ($33,704)

Page 7 of 10 · 197 filings